Cliff Nearing, It's Lilly's Turn to Restructure
Lilly's September reorganization will trim $1 billion in costs, but is as much about enhancing R&D productivity, the drugmaker says.
Lilly's September reorganization will trim $1 billion in costs, but is as much about enhancing R&D productivity, the drugmaker says.